Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001079973-21-001135
Filing Date
2021-11-12
Accepted
2021-11-12 16:25:37
Documents
74
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q opgn10qq3-0921.htm   iXBRL 10-Q 1712506
2 EXHIBIT 31.1 ex31x1.htm EX-31.1 7998
3 EXHIBIT 32.1 ex32x1.htm EX-32.1 3574
  Complete submission text file 0001079973-21-001135.txt   8766839

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE opgn-20210930.xsd EX-101.SCH 78736
5 XBRL CALCULATION FILE opgn-20210930_cal.xml EX-101.CAL 71704
6 XBRL DEFINITION FILE opgn-20210930_def.xml EX-101.DEF 313883
7 XBRL LABEL FILE opgn-20210930_lab.xml EX-101.LAB 470730
8 XBRL PRESENTATION FILE opgn-20210930_pre.xml EX-101.PRE 436092
9 EXTRACTED XBRL INSTANCE DOCUMENT opgn10qq3-0921_htm.xml XML 1624250
Mailing Address 9717 KEY WEST AVENUE SUITE 100 ROCKVILLE MD 20850
Business Address 9717 KEY WEST AVENUE SUITE 100 ROCKVILLE MD 20850 240-813-1260
OPGEN INC (Filer) CIK: 0001293818 (see all company filings)

EIN.: 061614015 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37367 | Film No.: 211403964
SIC: 8071 Services-Medical Laboratories